These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Pharmacodynamic and pharmacokinetic approaches to optimization of lomefloxacin]. Iakovlev SV Antibiot Khimioter; 1998; 43(10):42-5. PubMed ID: 9825110 [No Abstract] [Full Text] [Related]
4. [The use of Maxaquin (lomefloxacin hydrochloride) in the treatment of nonspecific inflammatory diseases and in the prevention of surgical interventions in urology]. Derevianko II; Lopatkin NA; Khodyreva LA; Kondrat'eva EM Urol Nefrol (Mosk); 1998; (5):14-8. PubMed ID: 9820038 [No Abstract] [Full Text] [Related]
5. [Lemofloxacin: antimicrobial ability and clinico-pharmacokinetic basis for use in urogenital infections]. Iakovlev SV Urologiia; 2002; (1):11-4. PubMed ID: 11877963 [TBL] [Abstract][Full Text] [Related]
7. [Difluoroquinolone lomefloxacin (Maxaquin): its role among fluoroquinolones, possibilities and prospectives]. Padeĭskaia EN Antibiot Khimioter; 1998; 43(10):4-9. PubMed ID: 9825101 [No Abstract] [Full Text] [Related]
8. Two new fluoroquinolones. Med Lett Drugs Ther; 1992 Jun; 34(872):58-60. PubMed ID: 1317502 [No Abstract] [Full Text] [Related]
13. Lomefloxacin and temafloxacin: two new fluoroquinolone antimicrobials. Symonds WT; Nix DE Clin Pharm; 1992 Sep; 11(9):753-66. PubMed ID: 1325892 [TBL] [Abstract][Full Text] [Related]
14. In vitro evaluation of lomefloxacin (NY-198 or SC-47111), a new difluoro-quinolone. Jones RN J Chemother; 1989 Jul; 1(4 Suppl):165-7. PubMed ID: 16312353 [No Abstract] [Full Text] [Related]
15. Antimicrobial activity of a new difluorinated quinolone: lomefloxacin (SC-47111). Mattina R; Cocuzza G; Cocuzza CE J Chemother; 1989 Jul; 1(4 Suppl):159-61. PubMed ID: 16312351 [No Abstract] [Full Text] [Related]
16. [Effect of lomefloxacin on the functional activity of the phagocytic system]. Mozhokina GN; Gracheva MP; Sokolova GB Antibiot Khimioter; 1996 Mar; 41(3):25-8. PubMed ID: 8967798 [TBL] [Abstract][Full Text] [Related]
17. Selection of a fluoroquinolone-class disk for susceptibility tests. Barry AL; Fuchs PC Am J Med; 1993 Mar; 94(3A):17S-22S. PubMed ID: 8383918 [TBL] [Abstract][Full Text] [Related]
18. [In vitro evaluation of lomefloxacin]. Dette GA; Knothe H Arzneimittelforschung; 1989 Aug; 39(8):832-5. PubMed ID: 2818672 [TBL] [Abstract][Full Text] [Related]
19. NM441: penetration into gynaecological tissues and in vitro activity against clinical isolates from obstetric and gynaecological patients. Mikamo H; Kawazoe K; Izumi K; Ito K; Tamaya T Drugs; 1995; 49 Suppl 2():326-30. PubMed ID: 8549350 [No Abstract] [Full Text] [Related]
20. In vitro antimicrobial activity of lomefloxacin against staphylococci, enterococci, and Enterobacteriaceae. Rossolini GM; Valentini S; Vaiani G; Satta G J Chemother; 1989 Jul; 1(4 Suppl):173-6. PubMed ID: 16312356 [No Abstract] [Full Text] [Related] [Next] [New Search]